Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Leptin Enhances the Release of Cytokines by Peripheral Blood Mononuclear Cells from Relapsing Multiple Sclerosis Patients

    Leptin, a hormone synthesized mainly by adipocytes, can modulate the immune response and seems to be involved in the induction of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosi...

    Giovanni Frisullo, Francesco Angelucci in Journal of Clinical Immunology (2004)

  2. No Access

    Article

    Glioblastoma in multiple sclerosis: a case report

    Cerebral tumor and multiple sclerosis (MS) relapses can show overlap** clinical and magnetic resonance imaging features. In a previous study we observed in relapsing MS patients increased T-bet, pSTAT1, and ...

    Giovanni Frisullo, Agata Katia Patanella, Viviana Nociti in Journal of Neuro-Oncology (2009)

  3. No Access

    Article

    Demyelinating encephalomyeloradiculitis with Balò-like lesions

    Alessandro Marti, Viviana Nociti, Giovanni Frisullo, Assunta Bianco in Journal of Neurology (2010)

  4. No Access

    Article

    CD8+ T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI

    Facioscapulohumeral muscular dystrophy (FSHD) is an inherited disease, and although strongly suggested, a contribution of inflammation to its pathogenesis has never been demonstrated. In FSHD patients, we foun...

    Giovanni Frisullo, Roberto Frusciante, Viviana Nociti in Journal of Clinical Immunology (2011)

  5. No Access

    Article

    Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer

    Domenico Plantone, Pietro Caliandro, Raffaele Iorio in Journal of Neurology (2011)

  6. No Access

    Article

    Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else?

    The spinal cord can be affected by multiple heterogeneous disorders often difficult to diagnose. We describe ten patients affected by a progressive ascending myelopathy with a poor prognosis. The patients, dur...

    Viviana Nociti, Anna Paola Batocchi, Marco Luigetti, Amelia Conte in Journal of Neurology (2011)

  7. Article

    Erratum to: Both trigeminal autonomic cephalalgia and trigeminal neuralgia in a child

    Valeria Rossi, Viviana Nociti, Concetta Palermo in Neurological Sciences (2014)

  8. No Access

    Article

    Rituximab as a first-line treatment in pediatric neuromyelitis optica spectrum disorder

    Giorgia Olivieri, Viviana Nociti, Raffaele Iorio in Neurological Sciences (2015)

  9. Article

    Open Access

    Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems

    Compared with other areas of the country, very limited data are available on multiple sclerosis (MS) prevalence in Central Italy. We aimed to estimate MS prevalence in the Lazio region and its geographical dis...

    Anna Maria Bargagli, Paola Colais, Nera Agabiti, Flavia Mayer in Journal of Neurology (2016)

  10. No Access

    Article

    Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis

    Multiple sclerosis (MS) is a chronic progressive inflammatory disease of the central nervous system (CNS) that leads to severe neurological disability. There is an interest in potential biomarkers that could p...

    Massimo Santoro, Viviana Nociti, Matteo Lucchini in Journal of Molecular Neuroscience (2016)

  11. No Access

    Article

    Systematic assessment and characterization of chronic pain in multiple sclerosis patients

    Pain is one of the most disabling clinical symptoms in patients with multiple sclerosis (MS). Several studies have already assessed the prevalence of pain in MS patients, reporting variable results, probably d...

    Diana Ferraro, Domenico Plantone, Franca Morselli, Giulia Dallari in Neurological Sciences (2018)

  12. No Access

    Article

    A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study

    In this independent, multicenter, retrospective study, we investigated the short-term persistence to treatment with first-line self-injectable or oral disease-modifying treatments (DMTs) in patients with relap...

    Roberta Lanzillo, Luca Prosperini, Claudio Gasperini in Journal of Neurology (2018)

  13. No Access

    Article

    Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study

    Two phase III trials have demonstrated the clinical and radiological efficacy of delayed-release dimethyl fumarate (DMF) in relapsing-remitting multiple sclerosis (RRMS). However, data on its safety and effect...

    Massimiliano Mirabella, Luca Prosperini, Matteo Lucchini, Laura Boffa in CNS Drugs (2018)

  14. Article

    Open Access

    Potential Effect of Cyclophosphamide on Bleb Survival in Five Patients with Multiple Sclerosis Who Underwent Glaucoma Surgery

    The purpose of this case series was to report the potential role of cyclophosphamide (CY) on bleb survival and to evaluate the safety of the trabeculectomy procedure under immunosuppressant systemic therapy.

    Andrea Giudiceandrea, Maria Emanuela Toro, Andrea Scupola in Ophthalmology and Therapy (2018)

  15. Article

    Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

    Extending the natalizumab interval after the 24th administration could reduce the risk of progressive multifocal leukoencephalopathy (PML). The objective is to evaluate the noninferiority of the efficacy of an...

    Marinella Clerico, Stefania Federica De Mercanti, Alessio Signori in Neurotherapeutics (2020)

  16. No Access

    Article

    Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study

    Patients with multiple sclerosis on long-term injectable therapies may suffer from the so-called “needle fatigue”, i.e., a waning commitment to continue with the prescribed injectable treatment. Therefore, alt...

    Luca Prosperini, Antonio Cortese, Matteo Lucchini, Laura Boffa in Journal of Neurology (2020)

  17. Article

    Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study

    In this independent, multicenter, post-marketing study, we directly compare induction immunosuppression versus escalation strategies on the risk of reaching the disability milestone of Expanded Disability Stat...

    Luca Prosperini, Chiara Rosa Mancinelli, Claudio Marcello Solaro in Neurotherapeutics (2020)

  18. Article

    Open Access

    Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis

    Dimethyl fumarate (DMF) is an oral drug approved for Relapsing Multiple Sclerosis (RMS) patients. Grade III lymphopenia is reported in 5–10% DMF-treated patients. Data on lymphocyte count (ALC) recovery after ...

    Matteo Lucchini, Luca Prosperini, Maria Chiara Buscarinu in Journal of Neurology (2021)

  19. Article

    Open Access

    Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study

    Patients with multiple sclerosis (MS) often receive disease-modifying therapies (DMTs) that can expose them to reactivation of potential occult hepatitis B virus (HBV) infection (pOBI). We aimed to evaluate th...

    Antonio Riccardo Buonomo, Giulio Viceconte, Massimiliano Calabrese in Journal of Neurology (2022)

  20. Article

    Open Access

    Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study

    Antonio Riccardo Buonomo, Giulio Viceconte, Massimiliano Calabrese in Journal of Neurology (2022)

previous disabled Page of 2